Correlation Between Shenzhen Centralcon and Suzhou Novoprotein

Can any of the company-specific risk be diversified away by investing in both Shenzhen Centralcon and Suzhou Novoprotein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Centralcon and Suzhou Novoprotein into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shenzhen Centralcon Investment and Suzhou Novoprotein Scientific, you can compare the effects of market volatilities on Shenzhen Centralcon and Suzhou Novoprotein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Centralcon with a short position of Suzhou Novoprotein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Centralcon and Suzhou Novoprotein.

Diversification Opportunities for Shenzhen Centralcon and Suzhou Novoprotein

0.82

Correlation Coefficient

Shenzhen Centralcon  Suzhou Novoprotein

Very poor diversification

The 3 months correlation between Shenzhen and Suzhou is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Centralcon Investment and Suzhou Novoprotein Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suzhou Novoprotein and Shenzhen Centralcon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Centralcon Investment are associated (or correlated) with Suzhou Novoprotein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suzhou Novoprotein has no effect on the direction of Shenzhen Centralcon i.e., Shenzhen Centralcon and Suzhou Novoprotein go up and down completely randomly.

Pair Corralation between Shenzhen Centralcon and Suzhou Novoprotein

Assuming the 90 days trading horizon Shenzhen Centralcon Investment is expected to under-perform the Suzhou Novoprotein. In addition to that, Shenzhen Centralcon is 1.49 times more volatile than Suzhou Novoprotein Scientific. It trades about -0.09 of its total potential returns per unit of risk. Suzhou Novoprotein Scientific is currently generating about -0.12 per unit of volatility. If you would invest  3,642  in Suzhou Novoprotein Scientific on October 26, 2024 and sell it today you would lose (505.00) from holding Suzhou Novoprotein Scientific or give up 13.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Shenzhen Centralcon Investment  vs.  Suzhou Novoprotein Scientific

Shenzhen Centralcon

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shenzhen Centralcon Investment has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Suzhou Novoprotein

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Shenzhen Centralcon and Suzhou Novoprotein

The main advantage of trading using opposite Shenzhen Centralcon and Suzhou Novoprotein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Centralcon position performs unexpectedly, Suzhou Novoprotein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suzhou Novoprotein will offset losses from the drop in Suzhou Novoprotein's long position.

The idea behind Shenzhen Centralcon Investment and Suzhou Novoprotein Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.